Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial
复制标题
DOI：
10.1016/s1470-2045(18)30380-2
复制
发表时间：
2018-10-01
期刊：
影响因子：
51.1
通讯作者：
Goldhirsch, Aron
中科院分区：
文献类型：
--
作者：
Galimberti, Viviana;Cole, Bernard F.;Goldhirsch, Aron
我们之前报道了3期IBCSG 23-01试验的5年结果，该试验比较了伴有一个或多个微转移性乳腺癌患者的无病生存率。
Background We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial comparing disease-free survival in patients with breast cancer with one or more micrometastatic (